• Je něco špatně v tomto záznamu ?

Axial motor clues to identify atypical parkinsonism: A multicentre European cohort study

CDJM. Borm, F. Krismer, GK. Wenning, K. Seppi, W. Poewe, MT. Pellecchia, P. Barone, EL. Johnsen, K. Østergaard, T. Gurevich, R. Djaldetti, L. Sambati, P. Cortelli, I. Petrović, VS. Kostić, H. Brožová, E. Růžička, MJ. Marti, E. Tolosa, M. Canesi,...

. 2018 ; 56 (-) : 33-40. [pub] 20180608

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, multicentrická studie, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc19035184

OBJECTIVE: Differentiating Parkinson's disease (PD) from atypical parkinsonian disorders (APD) such as Multiple System Atrophy, parkinsonian type (MSA-p) or Progressive Supranuclear Palsy (PSP-RS) can be challenging. Early signs of postural Instability and gait disability (PIGD) are considered clues that may signal presence of APD. However, it remains unknown which PIGD test - or combination of tests - can best distinguish PD from APD. We evaluated the discriminative value of several widely-used PIGD tests, and aimed to develop a short PIGD evaluation that can discriminate parkinsonian disorders. METHODS: In this multicentre cohort study patients were recruited by 11 European MSA Study sites. Patients were diagnosed using standardized criteria. Postural instability and gait disability was evaluated using interviews and several clinical tests. RESULTS: Nineteen PD, 21 MSA-p and 25 PSP-RS patients were recruited. PIGD was more common in APD compared to PD. There was no significant difference in axial symptoms between PSP-RS and MSA-p, except for self-reported falls (more frequent in PSP-RS patients). The test with the greatest discriminative power to distinguish APD from PD was the ability to perform tandem gait (AUC 0.83; 95% CI 71-94; p < 0.001), followed by the retropulsion test (AUC 0.8; 95% CI 0.69-0.91; p < 0.001) and timed-up-and-go test (TUG) (AUC 0.77; 95% CI 0.64-0.9; p = 0.001). The combination of these three tests yielded highest diagnostic accuracy (AUC 0.96; 95% CI 0.92-1.0; p < 0.001). CONCLUSIONS: Our study suggests that simple "bedside" PIGD tests - particularly the combination of tandem gait performance, TUG and retropulsion test - can discriminate APD from PD.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19035184
003      
CZ-PrNML
005      
20191015122516.0
007      
ta
008      
191007s2018 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.parkreldis.2018.06.015 $2 doi
035    __
$a (PubMed)29910157
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Borm, Carlijn D J M $u Radboud University Medical Centre, Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Parkinson Centre Nijmegen (ParC) Nijmegen, The Netherlands.
245    10
$a Axial motor clues to identify atypical parkinsonism: A multicentre European cohort study / $c CDJM. Borm, F. Krismer, GK. Wenning, K. Seppi, W. Poewe, MT. Pellecchia, P. Barone, EL. Johnsen, K. Østergaard, T. Gurevich, R. Djaldetti, L. Sambati, P. Cortelli, I. Petrović, VS. Kostić, H. Brožová, E. Růžička, MJ. Marti, E. Tolosa, M. Canesi, B. Post, J. Nonnekes, BR. Bloem, European MSA Study Group (EMSA-SG),
520    9_
$a OBJECTIVE: Differentiating Parkinson's disease (PD) from atypical parkinsonian disorders (APD) such as Multiple System Atrophy, parkinsonian type (MSA-p) or Progressive Supranuclear Palsy (PSP-RS) can be challenging. Early signs of postural Instability and gait disability (PIGD) are considered clues that may signal presence of APD. However, it remains unknown which PIGD test - or combination of tests - can best distinguish PD from APD. We evaluated the discriminative value of several widely-used PIGD tests, and aimed to develop a short PIGD evaluation that can discriminate parkinsonian disorders. METHODS: In this multicentre cohort study patients were recruited by 11 European MSA Study sites. Patients were diagnosed using standardized criteria. Postural instability and gait disability was evaluated using interviews and several clinical tests. RESULTS: Nineteen PD, 21 MSA-p and 25 PSP-RS patients were recruited. PIGD was more common in APD compared to PD. There was no significant difference in axial symptoms between PSP-RS and MSA-p, except for self-reported falls (more frequent in PSP-RS patients). The test with the greatest discriminative power to distinguish APD from PD was the ability to perform tandem gait (AUC 0.83; 95% CI 71-94; p < 0.001), followed by the retropulsion test (AUC 0.8; 95% CI 0.69-0.91; p < 0.001) and timed-up-and-go test (TUG) (AUC 0.77; 95% CI 0.64-0.9; p = 0.001). The combination of these three tests yielded highest diagnostic accuracy (AUC 0.96; 95% CI 0.92-1.0; p < 0.001). CONCLUSIONS: Our study suggests that simple "bedside" PIGD tests - particularly the combination of tandem gait performance, TUG and retropulsion test - can discriminate APD from PD.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a kohortové studie $7 D015331
650    _2
$a diferenciální diagnóza $7 D003937
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a neurologické poruchy chůze $x diagnóza $x epidemiologie $x patofyziologie $7 D020233
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a Parkinsonova nemoc $x diagnóza $x epidemiologie $x patofyziologie $7 D010300
650    _2
$a parkinsonské poruchy $x diagnóza $x epidemiologie $x patofyziologie $7 D020734
650    _2
$a posturální rovnováha $x fyziologie $7 D004856
650    _2
$a prospektivní studie $7 D011446
651    _2
$a Evropa $x epidemiologie $7 D005060
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Krismer, Florian $u Department of Neurology, Medical University Innsbruck, Austria.
700    1_
$a Wenning, Gregor K $u Department of Neurology, Medical University Innsbruck, Austria.
700    1_
$a Seppi, Klaus $u Department of Neurology, Medical University Innsbruck, Austria.
700    1_
$a Poewe, Werner $u Department of Neurology, Medical University Innsbruck, Austria.
700    1_
$a Pellecchia, Maria Teresa $u Centre for Neurodegenerative Diseases, Department of Medicine and Surgery, University of Salerno, Italy.
700    1_
$a Barone, Paolo $u Centre for Neurodegenerative Diseases, Department of Medicine and Surgery, University of Salerno, Italy.
700    1_
$a Johnsen, Erik L $u Department of Neurology, University Hospital, Aarhus, Denmark.
700    1_
$a Østergaard, Karen $u Department of Neurology, University Hospital, Aarhus, Denmark.
700    1_
$a Gurevich, Tanya $u Neurological Institute, Tel-Aviv Sourasky Medical Centre, Tel Aviv, Israel.
700    1_
$a Djaldetti, Ruth $u Department of Neurology, Rabin Medical Centre, Petach-Tiqva, Israel.
700    1_
$a Sambati, Luisa $u IRCCS Institute of Neurological Sciences of Bologna and Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.
700    1_
$a Cortelli, Pietro $u IRCCS Institute of Neurological Sciences of Bologna and Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.
700    1_
$a Petrović, Igor $u Institute of Neurology, Clinical Centre of Serbia, Belgrade, Serbia.
700    1_
$a Kostić, Vladimir S $u Institute of Neurology, Clinical Centre of Serbia, Belgrade, Serbia; Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
700    1_
$a Brožová, Hana $u Department of Neurology and Centre of Clinical Neuroscience Charles University in Prague, Czech Republic.
700    1_
$a Růžička, Evžen $u Department of Neurology and Centre of Clinical Neuroscience Charles University in Prague, Czech Republic.
700    1_
$a Marti, Maria Jose $u Neurology Service, Hospital Clínic Universitari, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona; Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Barcelona, Spain.
700    1_
$a Tolosa, Eduardo $u Department of Neurology, Parkinson Centre Milano, Italy.
700    1_
$a Canesi, Margherita $u Department of Neurology, Parkinson Centre Milano, Italy.
700    1_
$a Post, Bart $u Radboud University Medical Centre, Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Parkinson Centre Nijmegen (ParC) Nijmegen, The Netherlands.
700    1_
$a Nonnekes, Jorik $u Radboud University Medical Centre, Donders Institute for Brain, Cognition and Behaviour, Department of Rehabilitation, The Netherlands.
700    1_
$a Bloem, Bastiaan R $u Radboud University Medical Centre, Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Parkinson Centre Nijmegen (ParC) Nijmegen, The Netherlands. Electronic address: bas.bloem@radboudumc.nl.
710    2_
$a European MSA Study Group (EMSA-SG)
773    0_
$w MED00006198 $t Parkinsonism & related disorders $x 1873-5126 $g Roč. 56, č. - (2018), s. 33-40
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29910157 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20191007 $b ABA008
991    __
$a 20191015122942 $b ABA008
999    __
$a ok $b bmc $g 1451844 $s 1073734
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 56 $c - $d 33-40 $e 20180608 $i 1873-5126 $m Parkinsonism & related disorders $n Parkinsonism Relat Disord $x MED00006198
LZP    __
$a Pubmed-20191007

Najít záznam

Citační ukazatele

Možnosti archivace